Paratek Pharmaceuticals Stockholders To Receive Upfront Cash Payment Of $2.15 Per Share And A Contingent Value Right Of $0.85 Per Share On Achievement Of A Commercial Milestone For A Total Potential Value Of $3.00 Per Share
Portfolio Pulse from Happy Mohamed
Paratek Pharmaceuticals' stockholders are set to receive an upfront cash payment of $2.15 per share and a contingent value right of $0.85 per share upon achievement of a commercial milestone. This brings the total potential value to $3.00 per share.
August 04, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Paratek Pharmaceuticals' shareholders are set to receive a cash payment and a contingent value right, potentially increasing the value of their shares to $3.00 each.
The news directly impacts Paratek Pharmaceuticals' shareholders as they are set to receive an upfront cash payment and a contingent value right. This could potentially increase the value of their shares, making it a positive development for the company's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100